Nisa Investment Advisors
MBX

Nisa Investment Advisors’s MBX Biosciences MBX Stock Holding History

Nisa Investment Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.5K Hold
1,592
– – ﹤0.01% 1687
2025
Q4 		$50.2K Hold
1,592
– – ﹤0.01% 1612
2025
Q3 		$27.9K Hold
1,592
– – ﹤0.01% 1844
2025
Q2 		$18.2K Buy
+1,592
New +$16.2K ﹤0.01% 1988

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Nisa Investment Advisors's MBX Position: Q1 2026 in Review

Nisa Investment Advisors held its MBX Biosciences (MBX) position steady in Q1 2026 at 1,592 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Nisa Investment Advisors first reported a position in MBX in Q2 2025 and has held it in 4 quarters since. The position peaked at $50.2K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Nisa Investment Advisors held 1,592 shares of MBX Biosciences worth $47.5K as of Q1 2026.
  • Nisa Investment Advisors left its MBX Biosciences share count unchanged in Q1 2026.
  • MBX Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1687 holding.
  • Nisa Investment Advisors first reported a position in MBX Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Nisa Investment Advisors's MBX Biosciences position peaked at $50.2K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.